Clinical Trial Update: Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing the Bethesda Protocol to the Cambridge Method for detection of early-stage gastric cancer in CDH1 mutation carriers has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastric Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastric Cancer, Gastric Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2025-01-17